LABU250110C114000
- 0.15
- 0.000.00%
Direxion Daily S&P Biotech Bull 3x Shares ETF Newsroom
S&P 500 Positive for 'First Five Days,' Huang Sees Decades till Quantum | Wall Street Today
Alger Launches Russell Innovation ETF To Capitalize On Emerging Innovators
Solid Biosciences Outpaces Competitors In Duchenne Gene Therapy Development
Galapagos Unveils 2025 Split To Accelerate Innovation, Sharpen Strategic Focus
Assessing AbbVie: Insights From 17 Financial Analysts
Bird Flu Sparks Vaccine Stock Surge: ETFs To Watch As H5N1 Outbreak Intensifies
8 Health Care Stocks Whale Activity In Today's Session
Wednesday Market Falls, Quantum Computing Pulls Back Hard on Treasury Yield Crunch | Live Stock
Moderna Analyst Ratings
Neurocrine Biosciences Analyst Ratings
Compugen Announced That The First Patient Was Dosed In A Phase 1 Clinical Trial With Com503, A Potential First-in-class Antibody Against Il-18 Binding Protein Licensed By Compugen To Gilead
AbbVie Analyst Ratings
Express News | Moderna and Novavax Surge Over 5% and 6% Respectively on CDC Report of Rising Respiratory Illness
Nvidia, Palantir, Ionq, Novavax, And Tesla: Why These 5 Stocks Are On Investors' Radars Today
Here's How Much $1000 Invested In AbbVie 5 Years Ago Would Be Worth Today
U.S. stock market close: Inflation concerns lead to a decline in all indexes, NVIDIA fell 6% after reaching a new high.
① The Nasdaq China Golden Dragon Index fell by 0.2%, with China Concept Stocks showing mixed results; ② NVIDIA launched its personal computing product Project DIGITS; ③ XPENG Huaitian: Flying cars will be mass-produced and delivered in 2026; ④ Vaccine stocks soared, with Moderna rising nearly 12% and Novavax increasing by nearly 11%.
Tuesday Market Pulls Back After Nvidia All Time High | Wall Street Today
Arbutus Could Benefit From Big Pharma Bird Flu Vaccines: Jefferies
Stocks Sink As Bond Yields Soar, Nvidia Eyes Worst Day In 4 Months, Bitcoin Tumbles To $97,000: What's Driving Markets Tuesday?
Looking Into Gilead Sciences's Recent Short Interest